RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 92 filers reported holding RUBIUS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $14,000 | -86.4% | 17,022 | -9.0% | 0.00% | -75.0% |
| Q1 2022 | $103,000 | +1.0% | 18,700 | +77.3% | 0.00% | -20.0% |
| Q4 2021 | $102,000 | -53.6% | 10,549 | +17.1% | 0.01% | -64.3% |
| Q2 2021 | $220,000 | +340.0% | 9,011 | -9.9% | 0.01% | +600.0% |
| Q3 2020 | $50,000 | +4.2% | 10,000 | -6.5% | 0.00% | -33.3% |
| Q1 2020 | $48,000 | – | 10,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |